Toxic Adenoma laboratory findings: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
 
Line 3: Line 3:
{{CMG}} ; {{AE}} {{ADG}}
{{CMG}} ; {{AE}} {{ADG}}
==Overview==
==Overview==
Measurement of serum [[TSH]] is considered as the best initial test in the evaluation of thyroid disorders. The serum free [[T4]] and free or total [[T3]] levels are elevated or in the upper part of the normal range.  Findings of routine laboratory tests include elevated serum [[calcium]], elevated [[alkaline phosphatase]], elevated [[Ferritin|ferritin levels]], low ([[LDL Cholesterol|LDL]]) cholesterol levels.
Measurement of serum [[TSH]] is considered as the best initial test in the evaluation of [[thyroid]] disorders. The serum free [[T4]] and free or total [[T3]] levels are elevated or in the upper part of the normal range.  Findings of routine laboratory tests include elevated serum [[calcium]], elevated [[alkaline phosphatase]], elevated [[Ferritin|ferritin levels]], low ([[LDL Cholesterol|LDL]]) [[cholesterol]] levels.


==Laboratory Findings==
==Laboratory Findings==
*Measurement of serum [[TSH]] is considered as the initial test in the evaluation of thyroid disorders.<ref name="pmid12625976">{{cite journal |vauthors=Baloch Z, Carayon P, Conte-Devolx B, Demers LM, Feldt-Rasmussen U, Henry JF, LiVosli VA, Niccoli-Sire P, John R, Ruf J, Smyth PP, Spencer CA, Stockigt JR |title=Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease |journal=Thyroid |volume=13 |issue=1 |pages=3–126 |year=2003 |pmid=12625976 |doi=10.1089/105072503321086962 |url=}}</ref><ref name="pmid15496625">{{cite journal |vauthors=Hegedüs L |title=Clinical practice. The thyroid nodule |journal=N. Engl. J. Med. |volume=351 |issue=17 |pages=1764–71 |year=2004 |pmid=15496625 |doi=10.1056/NEJMcp031436 |url=}}</ref><ref name="pmid10434771">{{cite journal |vauthors=Cattaneo F, Bürgi U, Mueller B |title=[Goiter and nodular thyroid disease: clinical guidelines for diagnosis and treatment. (Waiting? Hormone therapy? Surgery? radioiodine?)] |language=German |journal=Ther Umsch |volume=56 |issue=7 |pages=356–63 |year=1999 |pmid=10434771 |doi=10.1024/0040-5930.56.7.356 |url=}}</ref><ref name="pmid8844728">{{cite journal |vauthors=Hurley DL, Gharib H |title=Evaluation and management of multinodular goiter |journal=Otolaryngol. Clin. North Am. |volume=29 |issue=4 |pages=527–40 |year=1996 |pmid=8844728 |doi= |url=}}</ref>  
*Measurement of serum [[TSH]] is considered as the initial test in the evaluation of [[thyroid]] disorders.<ref name="pmid12625976">{{cite journal |vauthors=Baloch Z, Carayon P, Conte-Devolx B, Demers LM, Feldt-Rasmussen U, Henry JF, LiVosli VA, Niccoli-Sire P, John R, Ruf J, Smyth PP, Spencer CA, Stockigt JR |title=Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease |journal=Thyroid |volume=13 |issue=1 |pages=3–126 |year=2003 |pmid=12625976 |doi=10.1089/105072503321086962 |url=}}</ref><ref name="pmid15496625">{{cite journal |vauthors=Hegedüs L |title=Clinical practice. The thyroid nodule |journal=N. Engl. J. Med. |volume=351 |issue=17 |pages=1764–71 |year=2004 |pmid=15496625 |doi=10.1056/NEJMcp031436 |url=}}</ref><ref name="pmid10434771">{{cite journal |vauthors=Cattaneo F, Bürgi U, Mueller B |title=[Goiter and nodular thyroid disease: clinical guidelines for diagnosis and treatment. (Waiting? Hormone therapy? Surgery? radioiodine?)] |language=German |journal=Ther Umsch |volume=56 |issue=7 |pages=356–63 |year=1999 |pmid=10434771 |doi=10.1024/0040-5930.56.7.356 |url=}}</ref><ref name="pmid8844728">{{cite journal |vauthors=Hurley DL, Gharib H |title=Evaluation and management of multinodular goiter |journal=Otolaryngol. Clin. North Am. |volume=29 |issue=4 |pages=527–40 |year=1996 |pmid=8844728 |doi= |url=}}</ref>  
*It should be measured in all patients with a [[thyroid nodule]] or [[goiter]].
*It should be measured in all patients with a [[thyroid nodule]] or [[goiter]].
*The serum free [[T4]] and free or total [[T3]] levels are elevated or in the upper part of the normal range.  
*The serum free [[T4]] and free or total [[T3]] levels are elevated or in the upper part of the normal range.  
*Toxic adenomas can be associated with overt or subclinical [[hyperthyroidism]].  
*Toxic adenomas can be associated with overt or subclinical [[hyperthyroidism]].  
**In overt hyperthyroidism, usually both serum (free) T4 and T3 are elevated.
**In overt [[hyperthyroidism]], usually both serum (free) [[T4]] and [[T3]] are elevated.
**Isolated T 3 toxicosis, in which the serum T 3 concentration is elevated but free T 4 is normal, occurs in approximately 1% of patients with hyperthyroidism.  
**Isolated [[T3]] toxicosis, in which the serum [[T3]] concentration is elevated but free [[T4]] is normal, occurs in approximately 1% of patients with [[hyperthyroidism]].  
*When the TSH is low, but both free T 4 and T 3 levels are normal, the patient has subclinical or mild hyperthyroidism, which is common in toxic multinodular goiter, especially in older patients.
*When the [[TSH]] is low, but both free [[T4]] and [[T3]] levels are normal, the patient has subclinical or mild [[hyperthyroidism]], which is common in [[toxic multinodular goiter]], especially in older patients.
*Findings of routine laboratory tests include:
*Findings of routine laboratory tests include:
** Elevated serum [[calcium]]
** Elevated serum [[calcium]]
** Elevated [[Alkaline phosphatase|alkaline phosphatase]]
** Elevated [[Alkaline phosphatase|alkaline phosphatase]]
** Elevated [[ferritin]] levels  
** Elevated [[ferritin]] levels  
** Low ([[LDL Cholesterol|LDL]]) cholesterol levels.
** Low ([[LDL Cholesterol|LDL]]) [[cholesterol]] levels.
{| class="wikitable"
{| class="wikitable"
!Tests
!Tests

Latest revision as of 18:13, 19 October 2017

Toxic Adenoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Toxic Adenoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Template:T On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Toxic Adenoma laboratory findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Toxic Adenoma laboratory findings

CDC on Toxic Adenoma laboratory findings

Toxic Adenoma laboratory findings in the news

Blogs on Toxic Adenoma laboratory findings

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Toxic Adenoma laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Aditya Ganti M.B.B.S. [2]

Overview

Measurement of serum TSH is considered as the best initial test in the evaluation of thyroid disorders. The serum free T4 and free or total T3 levels are elevated or in the upper part of the normal range. Findings of routine laboratory tests include elevated serum calcium, elevated alkaline phosphatase, elevated ferritin levels, low (LDL) cholesterol levels.

Laboratory Findings

Tests Findings
TSH Low
Free T4 Elevated
Total T3 Elevated
CMP
TSH receptor

antibodies

Negative
Thyroid peroxidase

antibodies

Negative

References

  1. ↑ Baloch Z, Carayon P, Conte-Devolx B, Demers LM, Feldt-Rasmussen U, Henry JF, LiVosli VA, Niccoli-Sire P, John R, Ruf J, Smyth PP, Spencer CA, Stockigt JR (2003). "Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease". Thyroid. 13 (1): 3–126. doi:10.1089/105072503321086962. PMID 12625976.
  2. ↑ Hegedüs L (2004). "Clinical practice. The thyroid nodule". N. Engl. J. Med. 351 (17): 1764–71. doi:10.1056/NEJMcp031436. PMID 15496625.
  3. ↑ Cattaneo F, Bürgi U, Mueller B (1999). "[Goiter and nodular thyroid disease: clinical guidelines for diagnosis and treatment. (Waiting? Hormone therapy? Surgery? radioiodine?)]". Ther Umsch (in German). 56 (7): 356–63. doi:10.1024/0040-5930.56.7.356. PMID 10434771.
  4. ↑ Hurley DL, Gharib H (1996). "Evaluation and management of multinodular goiter". Otolaryngol. Clin. North Am. 29 (4): 527–40. PMID 8844728.
Retrieved from "https://www.wikidoc.org/index.php?title=Toxic_Adenoma_laboratory_findings&oldid=1377378"